| |
|
Diagnostic Substances News
|
Meridian Bioscience falls on lowered 2010 outlook
2 hours, 30 minutes ago (AP)
Shares of Meridian Bioscience Inc. fell sharply Wednesday after the maker of flu testing and other health devices lowered its sales and earnings forecasts for the fiscal year.
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 12B | | Price
/ Earnings: | NM | | Price
/ Book: | 5.4 | | Net
Profit Margin (mrq): | -0.8% | | Price
To Free Cash Flow (mrq): | -527.1 | | Return
on Equity: | 0.0% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 2.8% |
|